Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme.

Expert review of pharmacoeconomics & outcomes research·2015
Same author

Exploring policy makers' perspectives on a clinical controversy: airway surgery for adult obstructive sleep apnoea.

Quality & safety in health care·2009
Same author

Efficiency measurement for hospitals owned by the Iranian social security organisation.

Journal of medical systems·2007
Same author

[Self assessment quality of life and lung diseases (SAQOL in patients with pulmonary carcinoma: influence to survival and impact of chronic obstructive pulmonary disease].

Pneumologie (Stuttgart, Germany)·2005
Same author

Implementation of a split-night protocol to improve efficiency in assessment and treatment of obstructive sleep apnoea.

Internal medicine journal·2005
Same author

Systematic assessment of clinical practice guidelines for the management of chronic obstructive pulmonary disease.

Respiratory medicine·2003

Related Experiment Video

Updated: Jul 25, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Domiciliary oxygen for chronic obstructive pulmonary disease.

J M Cranston1, A J Crockett, J R Moss

  • 1Flinders Medical Centre, Respiratory Unit, Bedford Park, South Australia, Australia 5042. jo.cranston@fmc.sa.gov.au

The Cochrane Database of Systematic Reviews
|October 20, 2005
PubMed
Summary

Domiciliary oxygen therapy improves survival for COPD patients with severe hypoxemia. However, it does not significantly impact survival for those with mild to moderate hypoxemia or only nocturnal desaturation.

More Related Videos

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Related Experiment Videos

Last Updated: Jul 25, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Area of Science:

  • Pulmonary Medicine
  • Respiratory Care

Background:

  • Domiciliary oxygen therapy is a primary treatment for hypoxemic chronic obstructive pulmonary disease (COPD).
  • Understanding its impact on patient outcomes is crucial for clinical practice.

Purpose of the Study:

  • To evaluate the effect of long-term domiciliary oxygen therapy on survival and quality of life in COPD patients.
  • To synthesize evidence from randomized controlled trials (RCTs) on oxygen therapy in COPD.

Main Methods:

  • Systematic review of RCTs identified through the Cochrane Airways Group COPD register.
  • Searches included terms for home or domiciliary oxygen therapy, current as of January 2005.
  • Data extraction was performed independently by two reviewers.

Main Results:

  • Six RCTs were included. Continuous oxygen therapy showed a significant mortality improvement in one trial (Peto OR 0.45).
  • Domiciliary oxygen therapy demonstrated a significant survival improvement over five years in another trial (Peto OR 0.42).
  • No significant survival benefit was observed for nocturnal oxygen therapy or continuous oxygen in mild to moderate hypoxemia.

Conclusions:

  • Long-term home oxygen therapy benefits survival in selected COPD patients with severe hypoxemia (PaO2 < 55 mm Hg).
  • Oxygen therapy did not improve survival in patients with mild to moderate hypoxemia or isolated nocturnal desaturation.